Direkt zur Hauptnavigation springen Direkt zum Inhalt springen
info(at)avldigital.remove-this.de
Deutsch English
Filtern nach
Aktive Filter
Letzte Suchanfragen

Ergebnisse für *

Zeige Ergebnisse 1 bis 2 von 2.

  1. Acquiring R&D projects: who, when, and what?
    evidence from antidiabetic drug development
    Autor*in: Malek, Jan; Newham, Melissa; Seldeslachts, Jo; Veugelers, Reinhilde
    Erschienen: 2024
    Verlag:  DIW Berlin, German Institute for Economic Research, Berlin

    This paper analyzes M&A patterns of R&D projects in the antidiabetics industry. For this purpose, we construct a database with all corporate individual antidiabetics R&D projects over the period 1997 - 2017, and add detailed information on firms'... mehr

    Zugang:
    Verlag (kostenfrei)
    Verlag (kostenfrei)
    Resolving-System (kostenfrei)
    Resolving-System (kostenfrei)

    Standort:
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    Signatur:
    DS 14
    Fernleihe:
    keine Fernleihe

     

    This paper analyzes M&A patterns of R&D projects in the antidiabetics industry. For this purpose, we construct a database with all corporate individual antidiabetics R&D projects over the period 1997 - 2017, and add detailed information on firms' technology dimension using patent information, next to their position in product markets. This allows us to identify the identity of targets and acquirers (who), the timing of acquisitions along the R&D process (when), and which type of R&D projects changes hands in terms of technology novelty (what). The main results can be summarized as follows. First, most of the action in M&As is in early R&D stages, still far from product markets. Second, most of the early-stage projects that change hands are high-risk/high-gain novel projects. Third, the industry leaders in the product markets are rather inactive in acquiring those novel early-stage projects. The likely acquirers of such projects are small or pipeline firms. Our results put in perspective the narrative that large incumbents acquire small targets with low-risk projects close to product launch.

     
    Export in Literaturverwaltung   RIS-Format
      BibTeX-Format
    Quelle: Verbundkataloge
    Sprache: Englisch
    Medientyp: Buch (Monographie)
    Format: Online
    Weitere Identifier:
    hdl: 10419/283239
    Schriftenreihe: Discussion papers / Deutsches Institut für Wirtschaftsforschung ; 2073
    Schlagworte: M&As; innovation; R&D; pharmaceutics; technology; novelty; patents
    Umfang: 1 Online-Ressource (circa 47 Seiten), Illustrationen
  2. Acquiring R&D projects: who, when, and what?
    evidence from antidiabetic drug development
    Autor*in: Malek, Jan; Newham, Melissa; Seldeslachts, Jo; Veugelers, Reinhilde
    Erschienen: [2024]
    Verlag:  KU Leuven, Faculty of Economics and Business, Dept. of Management, Strategy and Innovation (MSI), Leuven, Belgium

    Zugang:
    Verlag (kostenfrei)
    Verlag (kostenfrei)
    Verlag (kostenfrei)

    Standort:
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    Signatur:
    VS 597
    Fernleihe:
    keine Fernleihe
    Export in Literaturverwaltung   RIS-Format
      BibTeX-Format
    Quelle: Verbundkataloge
    Sprache: Englisch
    Medientyp: Buch (Monographie)
    Format: Online
    Schriftenreihe: MSI discussion paper ; no. 24, 01
    Schlagworte: M&As; innovation; R&D; pharmaceutics; technology; novelty; patents
    Umfang: 1 Online-Ressource (circa 47 Seiten), Illustrationen